Abstract
The main objective of this paper was to relate tardive dyskinesia to the total intake of neuroleptics. The data were based on a selected sample of geriatric patients, on accurate and complete information on chemotherapy, and on three neurological examinations. A 7-point rating scale was used to distinguish drug-induced from spurious motor abnormalities. Two statistical approaches demonstrated that the risk of oral dyskinesia increases with the exposure to neuroleptics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
